General
No CPD Points
Course Summary
Polly Dulley & Philip Morgan (15:23)
Tamoxifen had resurfaced in 2013 in the media because of NICE guidelines which approved the drug for prescription not only to patients with a diagnosis, but also to those at high risk of developing breast cancer. Polly Dulley and Philip Morgan discuss the clinical impact that the NICE guidelines may have on optometrists.
First published in DOCET OQ87 (2013).